Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macy's Inc (M) vs Medpace Holdings Inc (MEDP) Price & Performance

Macy's IncTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Macy's Inc vs Medpace Holdings Inc — how do they compare? Macy's Inc trades at $23.72 (market cap $6.45B), while Medpace Holdings Inc trades at $601.96 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 2.6× Macy's Inc's market cap, and Macy's Inc pays a 3.12% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

MMEDP
Market Cap
$6.45B$16.90B
Sector
Consumer CyclicalTechnology
52-Week High
$26.21$620.59
52-Week Low
$12.73$393.42
Enterprise Value
$10.26B$16.52B
Dividend Yield
3.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Macy's Inc

Macy's stock trades at $23.78, down 4.5% over 24 hours, with technical indicators showing a bullish moving average signal but neutral oscillators. The company demonstrates improving fundamentals with three consecutive quarterly earnings beats and positive cash flow trends. Recent institutional buying and analyst coverage reflect cautious optimism amid the company's turnaround efforts.

The stock presents value investment potential with attractive valuation multiples (P/E 10.13, P/S 0.3) and improving profitability. Key risks include retail sector headwinds and execution of the 'Bold New Chapter' strategy. The consensus price target of $24.83 suggests modest upside potential from current levels.

Medpace Holdings Inc

MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.

Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP